KEGG   Muntiacus reevesi (Reeves' muntjac): 136151340
Entry
136151340         CDS       T10466                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
mree  Muntiacus reevesi (Reeves' muntjac)
Pathway
mree01522  Endocrine resistance
mree01524  Platinum drug resistance
mree04012  ErbB signaling pathway
mree04066  HIF-1 signaling pathway
mree04068  FoxO signaling pathway
mree04110  Cell cycle
mree04115  p53 signaling pathway
mree04151  PI3K-Akt signaling pathway
mree04218  Cellular senescence
mree04630  JAK-STAT signaling pathway
mree04921  Oxytocin signaling pathway
mree04928  Parathyroid hormone synthesis, secretion and action
mree04934  Cushing syndrome
mree05160  Hepatitis C
mree05161  Hepatitis B
mree05163  Human cytomegalovirus infection
mree05165  Human papillomavirus infection
mree05166  Human T-cell leukemia virus 1 infection
mree05167  Kaposi sarcoma-associated herpesvirus infection
mree05169  Epstein-Barr virus infection
mree05200  Pathways in cancer
mree05202  Transcriptional misregulation in cancer
mree05203  Viral carcinogenesis
mree05205  Proteoglycans in cancer
mree05206  MicroRNAs in cancer
mree05210  Colorectal cancer
mree05211  Renal cell carcinoma
mree05212  Pancreatic cancer
mree05213  Endometrial cancer
mree05214  Glioma
mree05215  Prostate cancer
mree05216  Thyroid cancer
mree05217  Basal cell carcinoma
mree05218  Melanoma
mree05219  Bladder cancer
mree05220  Chronic myeloid leukemia
mree05222  Small cell lung cancer
mree05223  Non-small cell lung cancer
mree05224  Breast cancer
mree05225  Hepatocellular carcinoma
mree05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:mree00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    136151340 (CDKN1A)
   04630 JAK-STAT signaling pathway
    136151340 (CDKN1A)
   04066 HIF-1 signaling pathway
    136151340 (CDKN1A)
   04068 FoxO signaling pathway
    136151340 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    136151340 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    136151340 (CDKN1A)
   04115 p53 signaling pathway
    136151340 (CDKN1A)
   04218 Cellular senescence
    136151340 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    136151340 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    136151340 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    136151340 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    136151340 (CDKN1A)
   05206 MicroRNAs in cancer
    136151340 (CDKN1A)
   05205 Proteoglycans in cancer
    136151340 (CDKN1A)
   05203 Viral carcinogenesis
    136151340 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    136151340 (CDKN1A)
   05212 Pancreatic cancer
    136151340 (CDKN1A)
   05225 Hepatocellular carcinoma
    136151340 (CDKN1A)
   05226 Gastric cancer
    136151340 (CDKN1A)
   05214 Glioma
    136151340 (CDKN1A)
   05216 Thyroid cancer
    136151340 (CDKN1A)
   05220 Chronic myeloid leukemia
    136151340 (CDKN1A)
   05217 Basal cell carcinoma
    136151340 (CDKN1A)
   05218 Melanoma
    136151340 (CDKN1A)
   05211 Renal cell carcinoma
    136151340 (CDKN1A)
   05219 Bladder cancer
    136151340 (CDKN1A)
   05215 Prostate cancer
    136151340 (CDKN1A)
   05213 Endometrial cancer
    136151340 (CDKN1A)
   05224 Breast cancer
    136151340 (CDKN1A)
   05222 Small cell lung cancer
    136151340 (CDKN1A)
   05223 Non-small cell lung cancer
    136151340 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    136151340 (CDKN1A)
   05161 Hepatitis B
    136151340 (CDKN1A)
   05160 Hepatitis C
    136151340 (CDKN1A)
   05163 Human cytomegalovirus infection
    136151340 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    136151340 (CDKN1A)
   05169 Epstein-Barr virus infection
    136151340 (CDKN1A)
   05165 Human papillomavirus infection
    136151340 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    136151340 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    136151340 (CDKN1A)
   01522 Endocrine resistance
    136151340 (CDKN1A)
SSDB
Motif
Pfam: CDI
Other DBs
NCBI-GeneID: 136151340
NCBI-ProteinID: XP_065768452
LinkDB
Position
20:12549942..12566848
AA seq 161 aa
MSEPSRDAHQIPRSSKACRCLFGPVDSEQLRQDCDALMASCVQEARERWNFDFVTETPLQ
GDFAWERVRGLGLPKLYLPVGPRDDLGGGKRPSPSPALLQGASQEDHLDLSLSCTLVTRS
PERPEGTPGGPGPSQGRKRRQTSMTDFYHSKRRLICSKRKP
NT seq 486 nt   +upstreamnt  +downstreamnt
atgtccgagccgtccagggacgcgcatcaaatcccccgcagcagcaaggcctgccgctgc
ctctttggtccagtggacagcgagcagctgcgccaggactgcgacgccctcatggccagc
tgcgtgcaggaggcccgagagcggtggaacttcgactttgtcaccgagacgccgctgcag
ggggacttcgcctgggagcgcgtgaggggcctcggcctgcccaagctctacctgcccgtg
gggccccgagatgacctgggagggggcaagcggccgagcccctcgcccgccctgctgcag
ggcgcgtctcaggaggaccacttggacctgtcgctgtcctgcaccctcgtgactcgctcc
cctgagcggcccgaggggacccccggggggcctggcccctcccagggccggaaacggcgg
cagaccagcatgacagatttctaccactccaaacgcaggctgatctgctccaagaggaag
ccctaa

DBGET integrated database retrieval system